Tagged central-nervous-system

Five New 'Key Opinion Leaders' Appointed to Blinkcns Scientific Advisory Board
Press Release

Five New 'Key Opinion Leaders' Appointed to Blinkcns Scientific Advisory Board

 Dr. Angelo Antonini, Dr. Matteo Bologna, Roy Jones, Dr. Fidias Leon-Sarmiento, and Dr. Fabrizio Stocchi, will help guide company as they advance central nervous system research Read More
Blinktbi Accelerates Expansion of EyeStat Platform Technology With Appointment of Jeff Riley as Chief Executive Officer
Press Release

Blinktbi Accelerates Expansion of EyeStat Platform Technology With Appointment of Jeff Riley as Chief Executive Officer

 Mr. Riley to Lead Corporate Development Efforts as Company Targets New Clinical Applications for its Proprietary, FDA-Cleared Blink Reflex Technology Read More
Press Release

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Neuromyelitis Optica Spectrum Disorder

 Read More
Crossing the Blood-Brain Barrier - the Human Element of Abuse Potential Assessment, New Webinar Hosted by Xtalks
Press Release

Crossing the Blood-Brain Barrier - the Human Element of Abuse Potential Assessment, New Webinar Hosted by Xtalks

 CNS drug developers have to focus on physical safety and efficacy first, especially when developing products for rare disorders or diagnoses that are often unresponsive to other therapies. Although these products rarely have notable CNS mediated side effects, they fall under the FDA's requirement for an abuse potential assessment because they cross the blood-brain barrier. Read More
Upcoming Xtalks Webinar: Crossing the Blood-Brain Barrier? FDA Requires an Abuse Potential Assessment
Press Release

Upcoming Xtalks Webinar: Crossing the Blood-Brain Barrier? FDA Requires an Abuse Potential Assessment

 Read More